The effect of human chorionic gonadotropin on uterine preparatio

Phase 3

• Conditions: Female infertility of uterine origin.; Female infertility of uterine origin; N97.2

• Registration Number: IRCT20211121053124N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 140

Inclusion Criteria

Infertile women having at least one grade A or B fetus

Exclusion Criteria

Body mass index greater than 30
Male infertility
Uterine leiomyoma
Endometriosis grade 3, 4
Hydrosalpangitis
Withdraw to participation.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Biochemical pregnancy. Timepoint: Once, 14 days after fetus transfer. Method of measurement: Blood sampling.;Clinical pregnancy. Timepoint: Once, 6 to 8 weeks after fetus transfer. Method of measurement: Pregnancy sac observation in transvaginal ultrasound.